Le Lézard
Classified in: Health
Subject: MRR

Pharmaceuticals Wholesale & Distribution Market to grow by USD 896.5 Billion from 2024-2028, Driven by Growing Global Pharmaceutical Sales, Report on How AI is Driving Market Transformation - Technavio


NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global pharmaceuticals wholesale and distribution market size is estimated to grow by USD 896.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45%  during the forecast period. Growing global pharmaceutical sales is driving market growth, with a trend towards emergence of drones in pharmaceuticals wholesale and distribution. However, increased complexities due to time-bound deliveries and customization of supply chain  poses a challenge. Key market players include A.F. Hauser Pharmaceutical Inc., Alfresa Holdings Corp., AmerisourceBergen Corp., Attain Med Inc., Cardinal Health Inc., China Resources Pharmaceutical Group Ltd., Dakota Drug Inc., FFF Enterprises Inc., J M Smith Corp., McKesson Corp., MEDIPAL HOLDINGS CORP., Medline Industries LP, Morris and Dickson Co. LLC, Mutual Drug, Owens and Minor Inc., PHOENIX Pharmahandel GmbH and Co KG, Shanghai Fosun Pharmaceutical Group Co. Ltd., Sinopharm Group Co. Ltd., SUZUKEN CO. LTD., and The Cigna Group.

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Pharmaceuticals Wholesale And Distribution Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 - 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 9.45%

Market growth 2024-2028

USD 896.5 billion

Market structure

Fragmented

YoY growth 2022-2023 (%)

8.42

Regional analysis

North America, Asia, Europe, and Rest of World (ROW)

Performing market contribution

North America at 49%

Key countries

US, China, Canada, Japan, and Germany

Key companies profiled

A.F. Hauser Pharmaceutical Inc., Alfresa Holdings Corp., AmerisourceBergen Corp., Attain Med Inc., Cardinal Health Inc., China Resources Pharmaceutical Group Ltd., Dakota Drug Inc., FFF Enterprises Inc., J M Smith Corp., McKesson Corp., MEDIPAL HOLDINGS CORP., Medline Industries LP, Morris and Dickson Co. LLC, Mutual Drug, Owens and Minor Inc., PHOENIX Pharmahandel GmbH and Co KG, Shanghai Fosun Pharmaceutical Group Co. Ltd., Sinopharm Group Co. Ltd., SUZUKEN CO. LTD., and The Cigna Group

Market Driver

The Pharmaceutical Wholesale Distribution market is a significant segment of the pharmaceutical landscape. Wholesalers play a crucial role in this industry, acting as intermediaries between producers and retailers. Two types of wholesalers exist: Producer Wholesalers, who buy directly from manufacturers, and Merchant Wholesalers, who purchase from various sources. Branded Drugs and Generic Drugs are the two primary product categories. Ethical Pharma Products and Over-the-counter (OTC) Supply are essential sub-segments. The pharmaceutical landscape continues to evolve, with drug evaluation processes streamlining the introduction of Vaccines, Medical devices, and other innovations. Unmet medical needs drive the demand for new products. Generic Drug Promotion and Health Insurance schemes influence market dynamics. Track-and-trace systems ensure product authenticity and safety. The market includes Branded Pharmaceuticals, Generic Pharmaceuticals, and Over-the-counter (OTC) Pharmaceuticals. The Global Glycidol Market, a specialty chemical, is a significant component of this industry. Its applications include the production of polymers, resins, and surface active compounds used in Cosmetic Preparations, Laundry Detergents, Additives in plastics, Paints, Photographic Chemicals, Biocides, and Online/Offline sales channels. Valuation of Pharmaceutical Wholesale Distribution is influenced by market trends, production costs, and regulatory frameworks. 

Drones, unmanned aerial vehicles, are revolutionizing the logistics sector, particularly in the delivery of essential pharmaceutical supplies. In areas with inadequate road or railway infrastructure, drones offer a viable solution. They can transport pharmaceutical drugs and medicines to hard-to-reach remote destinations, improving market prospects for global pharmaceutical wholesale and distribution companies. Real-time information obtained from drones enables logistics firms to optimize their supply chain models effectively. This innovation in delivery methods is expected to significantly impact the pharmaceutical industry. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

 Market Challenges

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This pharmaceuticals wholesale and distribution market report extensively covers market segmentation by  

1.1 Branded drugs-  Pharmaceutical companies invest significantly in research and development to create branded drugs, which are approved by the FDA based on their safety, efficacy, and manufacturing methods. The high costs associated with R&D result in premium prices for these drugs, despite the availability of generic alternatives. In 2020, the FDA approved 53 new drugs, including Novartis AG's Kisqali, Roche's Ocrevus, and Gilead Sciences' Veklury. This approval of innovative treatments is expected to drive growth in the global pharmaceuticals wholesale and distribution market.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

Pharmaceutical Wholesale Distribution refers to the process of purchasing pharmaceutical products from manufacturers or importers and then distributing them to retailers, hospitals, and other healthcare providers. Wholesalers play a crucial role in this supply chain, acting as intermediaries between producers and end-users. There are two main types of wholesalers: Producer Wholesalers, who buy directly from manufacturers, and Merchant Wholesalers, who buy from various sources and sell to multiple customers. Agents and Brokers facilitate the sale of pharmaceutical products by acting as intermediaries between buyers and sellers. Branded Drugs and Generic Drugs are the two main categories of pharmaceutical products. Ethical Pharma Products are prescription drugs, while Over-the-Counter (OTC) and Institutional Supply drugs do not require a prescription. The pharmaceutical landscape is constantly evolving, with new drugs and treatments emerging to address Unmet Medical Needs. Drug evaluation and approval processes are rigorous to ensure safety and efficacy. Vaccines and Medical Devices are essential components of modern healthcare. Generic Drug Promotion and Health Insurance Schemes impact the pharmaceutical market significantly. Track-and-trace systems ensure the authenticity and safety of pharmaceutical products. The Global Glycidol Market is a subsegment of the specialty chemicals industry, with applications in various sectors, including Polymers, Resins, Surface Active Compounds, Cosmetic Preparations, Laundry Detergents, Additives in plastics, Paints, and Photographic Chemicals. The production of Glycidol and its derivatives involves complex chemical processes and requires a high level of expertise. Valuation of Pharmaceutical Companies depends on various factors, including their product portfolio, market share, and financial performance.

Market Research Overview

The Pharmaceutical Wholesale Distribution market refers to the process of procuring, storing, and distributing pharmaceutical products from manufacturers to retailers, hospitals, and other healthcare providers. Wholesalers play a crucial role in this supply chain, acting as intermediaries between producers and end-users. There are two main types of wholesalers: Producer Wholesalers, who buy directly from manufacturers, and Merchant Wholesalers, who purchase from various sources and sell to multiple customers. Agents and Brokers facilitate sales and marketing activities, while Branded Drugs, Generic Drugs, Ethical Pharma Products, OTC/Institutional Supply cater to diverse pharmaceutical landscape. Drug evaluation, vaccines, medical devices, and unmet medical needs are significant areas of focus. Generic drug promotion, health insurance schemes, and track-and-trace systems are key considerations. The pharmaceutical industry encompasses various sectors like Branded pharmaceuticals, Generic pharmaceuticals, Over-the-counter (OTC) pharmaceuticals, and others. The Global Glycidol Market, a specialty chemical used in the production of polymers, resins, and diversified materials, is a significant segment. Glycidol finds applications in cosmetic preparations, laundry detergents, additives in plastics, paints, photographic chemicals, biocides, and online/offline sales channels. Valuation of this market depends on various factors including production capacity, demand, and pricing trends.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation


7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 11:23
Once considered a niche practice, energy healing is now a fast-growing industry projected to reach $394.73 billion by 2030. With hospitals, wellness centers, and telehealth platforms integrating holistic practices such as Reiki and acupuncture,...

at 10:15
The HerHealth Oncology Congress 2025, a premier hybrid event presented by eMedEd and marketed by eMedEvents, successfully concluded at the Renaissance Orlando Resort & Spa. This transformative two-day conference convened leading oncologists, primary...

at 08:00
AbbVie today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate receptor alpha (FR?)-positive platinum-resistant ovarian cancer...

at 06:45
YupMD.com, a premier telehealth platform, is transforming the weight loss industry by providing convenient, science-backed solutions for individuals seeking sustainable and effective results. Through its innovative approach, YupMD connects patients...

at 06:07
Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today presents on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington's...

at 00:18
The official brand behind Prime Biome, a product developed under Bioventra's portfolio of advanced formulations, has issued a public advisory regarding unauthorized third-party resellers misrepresenting the product online. Reports indicate that...



News published on and distributed by: